Clinical TMS Society Announces New Executive Director


Fresno, CA. | August 29, 2018

The Clinical TMS Society is excited to announce that Ashleigh Servadio, MSC will assume the role of executive director effective September 1, 2018. Mrs. Servadio brings a wealth of experience as an association executive having served as the executive director of the Northern California Psychiatric Society (NCPS) and the manager of the Clinical TMS Society’s annual meetings in 2016 and 2017.

Mrs. Servadio takes over for Marcel Bourdase, MPA, CAE who joined the Society as the executive director in February 2016.  "We thank Marcel for his service and are excited about ongoing collaboration with Ashleigh, " said Clinical TMS Society president Paul Croarkin, DO. "Ashleigh is already a vital resource for our society and we look forward to her leadership.” 

Over the last two years, the Society has grown to over 500 members from over 25 countries around the world.

“I am excited and honored to join your society as the new executive director,” Ashleigh Servadio said. “Moving forward, I hope to lean on your continued input, participation and support, so we can be assured that the society will continue to flourish and more patients will benefit from TMS.”

The Clinical TMS Society was established in 2013 and includes Transcranial Magnetic Stimulation (TMS) providers with extensive clinical and research experience from across the United States and the world. The society is dedicated to optimizing clinical practice, awareness, and accessibility of Transcranial Magnetic Stimulation Therapy.